390 related articles for article (PubMed ID: 36015090)
1. Antibiotics and Carbohydrate-Containing Drugs Targeting Bacterial Cell Envelopes: An Overview.
Riu F; Ruda A; Ibba R; Sestito S; Lupinu I; Piras S; Widmalm G; Carta A
Pharmaceuticals (Basel); 2022 Jul; 15(8):. PubMed ID: 36015090
[TBL] [Abstract][Full Text] [Related]
2. Development of Whole-Cell Biosensors for Screening of Peptidoglycan-Targeting Antibiotics in a Gram-Negative Bacterium.
Yin J; Zhu Y; Liang Y; Luo Y; Lou J; Hu X; Meng Q; Zhu T; Yu Z
Appl Environ Microbiol; 2022 Sep; 88(18):e0084622. PubMed ID: 36040151
[TBL] [Abstract][Full Text] [Related]
3. A role for the Gram-negative outer membrane in bacterial shape determination.
Fivenson EM; Rohs PDA; Vettiger A; Sardis MF; Torres G; Forchoh A; Bernhardt TG
bioRxiv; 2023 Feb; ():. PubMed ID: 36778245
[TBL] [Abstract][Full Text] [Related]
4. Molecular Modeling and Simulation of the Peptidoglycan Layer of Gram-Positive Bacteria
Pokhrel R; Shakya R; Baral P; Chapagain P
J Chem Inf Model; 2022 Oct; 62(20):4955-4962. PubMed ID: 35981320
[TBL] [Abstract][Full Text] [Related]
5. Molecular modeling of Gram-positive bacteria peptidoglycan layer, selected glycopeptide antibiotics and vancomycin derivatives modified with sugar moieties.
Ślusarz R; Szulc M; Madaj J
Carbohydr Res; 2014 May; 389():154-64. PubMed ID: 24685455
[TBL] [Abstract][Full Text] [Related]
6. Structural variations and roles of rhamnose-rich cell wall polysaccharides in Gram-positive bacteria.
Guérin H; Kulakauskas S; Chapot-Chartier MP
J Biol Chem; 2022 Oct; 298(10):102488. PubMed ID: 36113580
[TBL] [Abstract][Full Text] [Related]
7. Synergy between Active Efflux and Outer Membrane Diffusion Defines Rules of Antibiotic Permeation into Gram-Negative Bacteria.
Krishnamoorthy G; Leus IV; Weeks JW; Wolloscheck D; Rybenkov VV; Zgurskaya HI
mBio; 2017 Oct; 8(5):. PubMed ID: 29089426
[TBL] [Abstract][Full Text] [Related]
8. Outer Membrane Disruption Overcomes Intrinsic, Acquired, and Spontaneous Antibiotic Resistance.
MacNair CR; Brown ED
mBio; 2020 Sep; 11(5):. PubMed ID: 32963002
[TBL] [Abstract][Full Text] [Related]
9. Unlocking the bacterial membrane as a therapeutic target for next-generation antimicrobial amphiphiles.
Mehta D; Saini V; Aggarwal B; Khan A; Bajaj A
Mol Aspects Med; 2021 Oct; 81():100999. PubMed ID: 34325929
[TBL] [Abstract][Full Text] [Related]
10. A comparative review of the lipoglycopeptides: oritavancin, dalbavancin, and telavancin.
Guskey MT; Tsuji BT
Pharmacotherapy; 2010 Jan; 30(1):80-94. PubMed ID: 20030476
[TBL] [Abstract][Full Text] [Related]
11. The bacterial cell wall as a source of antibacterial targets.
Green DW
Expert Opin Ther Targets; 2002 Feb; 6(1):1-19. PubMed ID: 11901475
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial agents targeting bacterial cell walls and cell membranes.
Bush K
Rev Sci Tech; 2012 Apr; 31(1):43-56. PubMed ID: 22849267
[TBL] [Abstract][Full Text] [Related]
13. Plantaricin A, Derived from Lactiplantibacillus plantarum, Reduces the Intrinsic Resistance of Gram-Negative Bacteria to Hydrophobic Antibiotics.
Meng F; Liu Y; Nie T; Tang C; Lyu F; Bie X; Lu Y; Zhao M; Lu Z
Appl Environ Microbiol; 2022 May; 88(10):e0037122. PubMed ID: 35499329
[TBL] [Abstract][Full Text] [Related]
14. Peptidoglycan Recycling Promotes Outer Membrane Integrity and Carbapenem Tolerance in Acinetobacter baumannii.
Islam N; Kazi MI; Kang KN; Biboy J; Gray J; Ahmed F; Schargel RD; Boutte CC; Dörr T; Vollmer W; Boll JM
mBio; 2022 Jun; 13(3):e0100122. PubMed ID: 35638738
[TBL] [Abstract][Full Text] [Related]
15. Identification of MupP as a New Peptidoglycan Recycling Factor and Antibiotic Resistance Determinant in
Fumeaux C; Bernhardt TG
mBio; 2017 Mar; 8(2):. PubMed ID: 28351916
[TBL] [Abstract][Full Text] [Related]
16. New perspectives for reassessing fosfomycin: applicability in current clinical practice.
Candel FJ; Matesanz David M; Barberán J
Rev Esp Quimioter; 2019 May; 32 Suppl 1(Suppl 1):1-7. PubMed ID: 31131586
[TBL] [Abstract][Full Text] [Related]
17. [Permeability barrier of bacterial cell envelopes as cause of resistance to antibiotics (author's transl)].
Fischer E; Braun V
Immun Infekt; 1981; 9(3):78-87. PubMed ID: 7019046
[TBL] [Abstract][Full Text] [Related]
18. A Biological Signature for the Inhibition of Outer Membrane Lipoprotein Biogenesis.
Lehman KM; Smith HC; Grabowicz M
mBio; 2022 Jun; 13(3):e0075722. PubMed ID: 35695460
[TBL] [Abstract][Full Text] [Related]
19. Bacterial cell wall compounds as promising targets of antimicrobial agents I. Antimicrobial peptides and lipopolyamines.
Martínez de Tejada G; Sánchez-Gómez S; Rázquin-Olazaran I; Kowalski I; Kaconis Y; Heinbockel L; Andrä J; Schürholz T; Hornef M; Dupont A; Garidel P; Lohner K; Gutsmann T; David SA; Brandenburg K
Curr Drug Targets; 2012 Aug; 13(9):1121-30. PubMed ID: 22664072
[TBL] [Abstract][Full Text] [Related]
20. From endolysins to Artilysin®s: novel enzyme-based approaches to kill drug-resistant bacteria.
Gerstmans H; Rodríguez-Rubio L; Lavigne R; Briers Y
Biochem Soc Trans; 2016 Feb; 44(1):123-8. PubMed ID: 26862197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
